424 related articles for article (PubMed ID: 31696251)
1. Towards a pro-resolving concept in systemic lupus erythematosus.
Boeltz S; Hagen M; Knopf J; Mahajan A; Schick M; Zhao Y; Erfurt-Berge C; Rech J; Muñoz LE; Herrmann M
Semin Immunopathol; 2019 Nov; 41(6):681-697. PubMed ID: 31696251
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE.
Muñoz LE; Janko C; Schulze C; Schorn C; Sarter K; Schett G; Herrmann M
Autoimmun Rev; 2010 Nov; 10(1):38-42. PubMed ID: 20817127
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus.
Biermann MHC; Boeltz S; Pieterse E; Knopf J; Rech J; Bilyy R; van der Vlag J; Tincani A; Distler JHW; Krönke G; Schett GA; Herrmann M; Muñoz LE
Front Immunol; 2018; 9():989. PubMed ID: 29867966
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory etiopathogenesis of systemic lupus erythematosus: an update.
Podolska MJ; Biermann MH; Maueröder C; Hahn J; Herrmann M
J Inflamm Res; 2015; 8():161-71. PubMed ID: 26316795
[TBL] [Abstract][Full Text] [Related]
5. Self-dsDNA in the pathogenesis of systemic lupus erythematosus.
Bai Y; Tong Y; Liu Y; Hu H
Clin Exp Immunol; 2018 Jan; 191(1):1-10. PubMed ID: 28836661
[TBL] [Abstract][Full Text] [Related]
6. Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE.
Mahajan A; Herrmann M; Muñoz LE
Front Immunol; 2016; 7():35. PubMed ID: 26904025
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE).
Janko C; Schorn C; Grossmayer GE; Frey B; Herrmann M; Gaipl US; Munoz LE
Autoimmun Rev; 2008 Oct; 8(1):9-12. PubMed ID: 18703173
[TBL] [Abstract][Full Text] [Related]
8. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
Chauhan SK; Rai R; Singh VV; Rai M; Rai G
Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
[TBL] [Abstract][Full Text] [Related]
9. SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus.
Jorge AM; Lao T; Kim R; Licciardi S; El Khoury J; Luster AD; Means TK; Ramirez-Ortiz ZG
J Immunol; 2022 Feb; 208(4):955-967. PubMed ID: 35082161
[TBL] [Abstract][Full Text] [Related]
10. Circulating microparticles in systemic Lupus Erythematosus.
Nielsen CT
Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
[TBL] [Abstract][Full Text] [Related]
11. Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects.
Soni C; Reizis B
Front Immunol; 2019; 10():1601. PubMed ID: 31354738
[TBL] [Abstract][Full Text] [Related]
12. CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus.
Chavula T; To S; Smith J; Pedroza M; Nimri J; Devaraj S; Wenderfer S; Vogel TP; Agarwal SK
J Autoimmun; 2024 May; 145():103197. PubMed ID: 38447248
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in the pathogenesis of systemic lupus erythematosus.
Munoz LE; van Bavel C; Franz S; Berden J; Herrmann M; van der Vlag J
Lupus; 2008 May; 17(5):371-5. PubMed ID: 18490410
[TBL] [Abstract][Full Text] [Related]
14. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.
Biermann MH; Veissi S; Maueröder C; Chaurio R; Berens C; Herrmann M; Munoz LE
Expert Rev Clin Immunol; 2014 Sep; 10(9):1151-64. PubMed ID: 25081199
[TBL] [Abstract][Full Text] [Related]
15. Clearance deficiency and systemic lupus erythematosus (SLE).
Gaipl US; Munoz LE; Grossmayer G; Lauber K; Franz S; Sarter K; Voll RE; Winkler T; Kuhn A; Kalden J; Kern P; Herrmann M
J Autoimmun; 2007; 28(2-3):114-21. PubMed ID: 17368845
[TBL] [Abstract][Full Text] [Related]
16. Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus.
Yang F; He Y; Zhai Z; Sun E
J Immunol Res; 2019; 2019():3638562. PubMed ID: 31871956
[TBL] [Abstract][Full Text] [Related]
17. Removal of dying cells and systemic lupus erythematosus.
Grossmayer GE; Munoz LE; Gaipl US; Franz S; Sheriff A; Voll RE; Kalden JR; Herrmann M
Mod Rheumatol; 2005; 15(6):383-90. PubMed ID: 17029100
[TBL] [Abstract][Full Text] [Related]
18. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
20. Human neutrophils in auto-immunity.
Thieblemont N; Wright HL; Edwards SW; Witko-Sarsat V
Semin Immunol; 2016 Apr; 28(2):159-73. PubMed ID: 27036091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
